Lv1
20 积分 2024-04-10 加入
非小细胞肺癌新辅助治疗疗效病理评估专家共识
10小时前
待确认
抗肿瘤药物相关间质性肺病诊治专家共识
1个月前
已完结
Optimal Cut-Off with NGS for Metamplification Andclinical Relevance to MET Inhibitor in Non-Small-Cell Lung Cancer
1个月前
已关闭
The roles of epidermal growth factor receptor (EGFR) inhibitors in the management of lung cancer
2个月前
已完结
MET alterations in advanced non-small cell lung cancer
2个月前
已完结
Evolving roles of MET as a therapeutic target in NSCLC and beyond
2个月前
已完结
Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib
2个月前
已完结
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC
4个月前
已完结
The Nonclinical Safety Assessment of a Novel Anti-CEACAM5 Antibody Exatecan Conjugate Predicts a Low Risk for Interstitial Lung Disease (ILD) in Patients—The Putative Mechanism Behind ILD
4个月前
已完结
Overcoming therapy resistance in EGFR-mutant lung cancer
5个月前
已完结
皖公网安备34019202002308
